SiriusPoint Ltd. (SPNT) 10-Year Financial Performance & Capital Metrics

SPNT • • Insurance & Managed Care

Financial ServicesReinsuranceHybrid Reinsurance/InsuranceIntegrated Reinsurance & Insurance Providers

AboutSiriusPoint Ltd. provides multi-line insurance and reinsurance products and services worldwide. The company operates through two segments, Reinsurance, and Insurance & Services. The Reinsurance segment provides coverage to various product lines, which includes aviation and space, casualty, contingency, credit and bond, marine and energy, mortgage, and property to insurance and reinsurance companies, government entities, and other risk bearing vehicles. The Insurance & Services segment offers coverage to various product lines comprising accident and health, environmental, workers' compensation, and other lines of business, including a cross section of property and casualty lines. The company was formerly known as Third Point Reinsurance Ltd. and changed its name to SiriusPoint Ltd. in February 2021. SiriusPoint Ltd. was incorporated in 2011 and is headquartered in Pembroke, Bermuda.Show more

Revenue $2.61B -3.3%
Combined Ratio 91.08% +3.3%
Net Income $200M -43.7%
Return on Equity 8.95% -41.8%
Medical Cost Ratio 72.13% +5.1%
Operating Margin 8.92% -24.4%
Net Margin 7.65% -41.7%
ROA 1.57% -47.0%
Equity / Assets 15.48% -21.3%
Book Value per Share 11.44 -23.3%
Tangible BV/Share 11.44 -18.4%
Debt/Equity 0.33 +6.1%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Profitable underwriting: 91.1% combined ratio

✗Weaknesses

✗Weak 3Y average ROE of 2.5%

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y17.3%

5Y21.7%

3Y5.52%

TTM8.63%

Profit (Net Income) CAGR

10Y14.77%

5Y-0.07%

3Y50.97%

TTM-36.99%

EPS CAGR

10Y8.27%

5Y-13.6%

3Y56.76%

TTM-2.21%

ROCE

10Y Avg0.77%

5Y Avg1.1%

3Y Avg0.18%

Latest1.84%

Peer Comparison

Integrated Reinsurance & Insurance Providers

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
SPNTSiriusPoint Ltd.	2.38B	20.40	19.62	-3.28%	6.98%	8.97%	3.13%	0.33
EGEverest Re Group, Ltd.	13.48B	321.21	10.11	18.06%	3.15%	3.59%	36.76%	0.43
HGHamilton Insurance Group, Ltd.	1.7B	26.37	7.19	47.03%	15.65%	15.98%	44.62%	0.06

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Revenue+	577.95M	708.54M	926.71M	377.51M	979M	884.5M	2.22B	2.17B	2.7B	2.61B
Revenue Growth %	0.09%	0.23%	0.31%	-0.59%	1.59%	-0.1%	1.52%	-0.02%	0.24%	-0.03%
Medical Costs & Claims+	615.02M	626.47M	571.64M	654.52M	699.1M	652.4M	1.71B	2.05B	1.85B	1.89B
Medical Cost Ratio %	-	-	-	-	-	-	-	-	-	-
Gross Profit+	-37.08M	82.07M	355.07M	-277.01M	279.9M	232.1M	510.4M	121.3M	848.4M	728.4M
Gross Margin %	-	-	-	-	-	-	-	-	-	-
Gross Profit Growth %	-1.36%	3.21%	3.33%	-1.78%	2.01%	-0.17%	1.2%	-0.76%	5.99%	-0.14%
Operating Expenses+	53.27M	47.6M	61.33M	44.47M	78.6M	80.2M	465.3M	544M	529.7M	495.3M
OpEx / Revenue %	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	0	0	0	0	0	0	5.9M	8.1M	11.1M	11.9M
Combined Ratio %	-	-	-	-	-	-	-	-	-	-
Operating Income+	-90.34M	34.47M	293.75M	-321.48M	201.3M	151.9M	45.1M	-422.7M	318.7M	233.1M
Operating Margin %	-	-	-	-	-	-	-	-	-	-
Operating Income Growth %	-2.45%	1.38%	7.52%	-2.09%	1.63%	-0.25%	-0.7%	-10.37%	1.75%	-0.27%
EBITDA+	-83.11M	42.7M	301.97M	-313.25M	209.5M	160.1M	51M	-414.6M	329.8M	245M
EBITDA Margin %	-	-	-	-	-	-	-	-	-	-
Interest Expense	7.24M	8.23M	8.22M	8.23M	8.2M	8.2M	34M	38.6M	64.1M	69.6M
Non-Operating Income	-7.24M	-8.23M	-8.22M	-8.23M	-8.2M	-8.2M	-34M	-38.6M	-64.1M	-69.6M
Pretax Income+	-90.34M	34.47M	293.75M	-321.48M	201.3M	151.9M	45.1M	-422.7M	318.7M	233.1M
Pretax Margin %	-	-	-	-	-	-	-	-	-	-
Income Tax+	-2.9M	5.59M	11.98M	-4.01M	700K	8.1M	-10.7M	-36.7M	-45M	30.7M
Effective Tax Rate %	-	-	-	-	-	-	-	-	-	-
Net Income+	-87.39M	27.64M	277.8M	-317.69M	200.6M	143.8M	58.1M	-386.8M	354.8M	199.9M
Net Margin %	-	-	-	-	-	-	-	-	-	-
Net Income Growth %	-2.73%	1.32%	9.05%	-2.14%	1.63%	-0.28%	-0.6%	-7.66%	1.92%	-0.44%
EPS (Diluted)+	-0.84	0.26	2.64	-3.27	2.16	1.53	0.27	-2.51	1.85	1.04
EPS Growth %	-2.79%	1.31%	9.15%	-2.24%	1.66%	-0.29%	-0.82%	-10.3%	1.74%	-0.44%
EPS (Basic)	-0.84	0.26	2.71	-3.27	2.18	1.54	0.28	-2.51	1.93	1.06
Diluted Shares Outstanding	104M	105.56M	105.23M	97.05M	92.65M	92.96M	150.16M	160.23M	169.61M	169.47M

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Assets+	3.55B	3.9B	4.67B	3.09B	3.44B	3.54B	10.62B	11.04B	12.87B	12.52B
Asset Growth %	0.24%	0.1%	0.2%	-0.34%	0.11%	0.03%	2%	0.04%	0.17%	-0.03%
Total Investment Assets+	2.27B	2.56B	2.96B	1.52B	989.7M	1.16B	4.53B	8.77B	6.03B	5.71B
Long-Term Investments	2.27B	2.56B	2.96B	1.52B	125.07M	105.3M	3.62B	5.15B	5.66B	5.39B
Short-Term Investments	0	0	0	0	0	0	1.08B	3.62B	371.6M	2.89B
Total Current Assets+	30.78M	16.46M	11.76M	711.39M	0	0	0	5.26B	969.2M	0
Cash & Equivalents	20.41M	9.95M	8.2M	104.18M	639.41M	526M	999.8M	705.3M	969.2M	682M
Receivables	0	1000K	0	0	1000K	1000K	1000K	1000K	1000K	1000K
Other Current Assets	0	0	0	0	-1.26B	-1.1B	-5.52B	3.62B	2.89B	-8.46B
Goodwill & Intangibles+	197.09M	221.62M	258.79M	203.84M	0	0	171.9M	163.8M	152.7M	140.8M
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	197.09M	221.62M	258.79M	203.84M	0	0	0	163.8M	152.7M	0
PP&E (Net)	0	0	0	0	0	0	0	25.9M	25.6M	0
Other Assets	-197.09M	-221.62M	-258.79M	-203.84M	-125.07M	-105.3M	-3.79B	-5.17B	-19.5M	-5.53B
Total Liabilities	2.15B	2.45B	2.9B	1.88B	2.03B	1.97B	8.12B	8.95B	10.34B	10.59B
Total Debt+	113.38M	113.56M	113.73M	113.91M	114.09M	114.3M	816.7M	778M	786.2M	639.1M
Net Debt	92.97M	103.6M	105.54M	9.73M	-525.33M	-411.7M	-183.1M	72.7M	-183M	-42.9M
Long-Term Debt	113.38M	113.56M	113.73M	113.91M	114.09M	114.3M	816.7M	778M	786.2M	639.1M
Short-Term Debt	0	0	0	0	0	0	0	18M	6.7M	0
Total Current Liabilities+	611.05M	113.56M	846.45M	76.96M	0	0	0	266.6M	6.2M	0
Accounts Payable	611.05M	953.09M	846.45M	76.96M	99.76M	95.7M	924.6M	1.08B	2.02B	1.8B
Deferred Revenue	0	0	816.83M	0	0	0	0	-18M	0	0
Other Current Liabilities	-611.05M	-956.54M	-1.66B	-79.26M	-102.81M	-98.78M	-924.6M	-813.6M	-2.02B	-1.8B
Deferred Taxes	-1000K	-1000K	-1000K	-1000K	0	0	1000K	1000K	1000K	1000K
Other Liabilities	950.87M	2.33B	827.79M	0	-114.26M	-115.3M	-912.7M	7.82B	9.45B	-723.8M
Total Equity+	1.4B	1.45B	1.77B	4.46B	1.41B	1.57B	2.5B	2.08B	2.53B	1.94B
Equity Growth %	-0.1%	0.04%	0.22%	1.52%	-0.68%	0.11%	0.6%	-0.17%	0.22%	-0.23%
Shareholders Equity	1.38B	1.41B	1.66B	1.2B	1.41B	1.56B	2.5B	2.07B	2.51B	1.94B
Minority Interest	16.16M	35.67M	113.63M	3.26B	0	1.4M	-400K	7.9M	16.7M	1.4M
Retained Earnings	288.59M	316.22M	594.02M	276.33M	476.95M	620.4M	665M	262.2M	601M	784.9M
Common Stock	10.55M	10.65M	10.72M	9.36M	9.42M	9.6M	16.2M	16.2M	16.8M	11.6M
Accumulated OCI	0	0	0	0	0	0	-200K	-45M	3.1M	-4.1M
Return on Equity (ROE)	-0.06%	0.02%	0.17%	-0.1%	0.07%	0.1%	0.03%	-0.17%	0.15%	0.09%
Return on Assets (ROA)	-0.03%	0.01%	0.06%	-0.08%	0.06%	0.04%	0.01%	-0.04%	0.03%	0.02%
Equity / Assets	-	-	-	-	-	-	-	-	-	-
Debt / Equity	0.08x	0.08x	0.06x	0.03x	0.08x	0.07x	0.33x	0.37x	0.31x	0.33x
Book Value per Share	13.42	13.73	16.82	45.99	15.26	16.84	16.67	13.00	14.92	11.44
Tangible BV per Share	-	-	-	-	-	-	-	-	-	-

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	187.78M	4.77M	-78.54M	13.39M	141.11M	73.36M	1.6M	293.3M	581.3M	74.7M
Operating CF Growth %	0.53%	-0.97%	-17.46%	1.17%	9.54%	-0.48%	-0.98%	182.31%	0.98%	-0.87%
Operating CF / Revenue %	-	-	-	-	-	-	-	-	-	-
Net Income	-87.44M	28.88M	281.77M	-317.47M	200.62M	143.86M	55.8M	-386M	363.7M	202.4M
Depreciation & Amortization	-1.04M	-1.04M	4.94M	4.94M	3.96M	-4.01M	5.9M	13.9M	11.1M	11.9M
Stock-Based Compensation	10.87M	8.94M	3.6M	4.96M	7M	6.6M	11.4M	30.5M	21.4M	20.7M
Deferred Taxes	-23.21M	-60.76M	-8.91M	-5.16M	-3.96M	4.01M	0	-53.9M	-60.2M	0
Other Non-Cash Items	43.55M	-58.03M	-460.5M	242.28M	-243.96M	-255.21M	-413.9M	393.6M	83.1M	7.3M
Working Capital Changes	245.05M	86.79M	100.57M	83.84M	177.45M	178.11M	342.4M	295.2M	162.2M	-167.6M
Cash from Investing+	-163.88M	-53.28M	23.05M	377.56M	786.86M	6.11M	208.6M	-1.3B	-332.2M	343.6M
Capital Expenditures	0	0	0	0	0	0	0	-800K	0	0
Acquisitions	0	18.28M	73.98M	-97.95M	0	0	652.4M	800K	0	0
Purchase of Investments	-3.9B	-4.99B	-3.89B	-4.34B	-418.46M	-446.96M	-3.41B	-6.16B	-4.97B	-2.73B
Sale/Maturity of Investments	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K
Other Investing	118.81M	390.05M	-362.48M	432.31M	-886K	-94.9M	77.9M	4.5M	5.5M	6.2M
Cash from Financing+	-32.22M	38.05M	53.73M	-226.94M	12.65M	-19.48M	24.3M	-23.7M	-61.5M	-625M
Dividends Paid	-38K	-38K	-3.22M	-3.22M	-2.72M	-1.29M	-12.2M	-16M	-16M	-16M
Share Repurchases	0	-7.39M	-40.86M	-138.71M	0	-300K	0	-12.1M	0	-299.7M
Stock Issued	4.33M	5.14M	1.5M	0	1.9M	0	50.8M	0	27.8M	18.4M
Debt Issuance (Net)	1000K	0	0	0	0	0	0	1000K	-1000K	-1000K
Other Financing	-79.56M	45.48M	97.82M	-84.94M	13.47M	-17.89M	-14.3M	-13.2M	-55.3M	-203.7M
Net Change in Cash+	-8.33M	-10.46M	-1.75M	164M	940.62M	59.98M	234.5M	-1.03B	187.6M	-206.7M
Exchange Rate Effect	0	0	0	0	0	0	0	0	0	0
Cash at Beginning	28.73M	20.41M	9.95M	549.33M	713.34M	1.65B	1.71B	1.95B	913.7M	1.1B
Cash at End	20.41M	9.95M	8.2M	713.34M	1.65B	1.71B	1.95B	913.7M	1.1B	894.6M
Free Cash Flow+	187.78M	4.77M	-78.54M	13.39M	141.11M	73.36M	1.6M	292.5M	581.3M	74.7M
FCF Growth %	0.53%	-0.97%	-17.46%	1.17%	9.54%	-0.48%	-0.98%	181.81%	0.99%	-0.87%
FCF Margin %	-	-	-	-	-	-	-	-	-	-
FCF per Share	1.81	0.05	-0.75	0.14	1.52	0.79	0.01	1.83	3.43	0.44

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Combined Ratio	115.63%	95.14%	68.3%	185.16%	79.44%	82.83%	97.97%	119.46%	88.21%	91.08%
Medical Cost Ratio	106.41%	88.42%	61.68%	173.38%	71.41%	73.76%	77.06%	94.41%	68.61%	72.13%
Return on Equity (ROE)	-5.93%	1.94%	17.26%	-10.19%	6.83%	9.65%	2.86%	-16.87%	15.38%	8.95%
Return on Assets (ROA)	-2.73%	0.74%	6.49%	-8.19%	6.15%	4.12%	0.82%	-3.57%	2.97%	1.57%
Equity / Assets	39.37%	37.21%	37.88%	144.61%	41.11%	44.28%	23.58%	18.87%	19.66%	15.48%
Book Value / Share	13.42	13.73	16.82	45.99	15.26	16.84	16.67	13	14.92	11.44
Debt / Equity	0.08x	0.08x	0.06x	0.03x	0.08x	0.07x	0.33x	0.37x	0.31x	0.33x
Revenue Growth	9.02%	22.6%	30.79%	-59.26%	159.33%	-9.65%	151.52%	-2.39%	24.44%	-3.28%

Revenue by Segment

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Insurance and Services	-	-	-	-	-	-	522.8M	1.09B	1.25B	1.15B
Insurance and Services Growth	-	-	-	-	-	-	-	107.88%	14.94%	-7.62%
Reinsurance	-	-	-	-	-	-	1.21B	1.21B	1.03B	1.05B
Reinsurance Growth	-	-	-	-	-	-	-	0.18%	-14.98%	1.33%
Property and Casualty Reinsurance	-	-	-	-	-	610.85M	-	-	-	-
Property and Casualty Reinsurance Growth	-	-	-	-	-	-	-	-	-	-
Corporate	-	-	-	-	-	-	-	-	-	-
Corporate Growth	-	-	-	-	-	-	-	-	-	-
Property, Liability and Casualty Insurance Product Line	602.82M	590.19M	547.06M	621.44M	700.14M	-	-	-	-	-
Property, Liability and Casualty Insurance Product Line Growth	-	-2.09%	-7.31%	13.60%	12.66%	-	-	-	-	-
Catastrophe Risk Management	8K	-	-	-	-	-	-	-	-	-
Catastrophe Risk Management Growth	-	-	-	-	-	-	-	-	-	-

Frequently Asked Questions

Valuation & Price

SiriusPoint Ltd. (SPNT) has a price-to-earnings (P/E) ratio of 19.6x. This is roughly in line with market averages.

Growth & Financials

SiriusPoint Ltd. (SPNT) saw revenue decline by 3.3% over the past year.

Yes, SiriusPoint Ltd. (SPNT) is profitable, generating $198.3M in net income for fiscal year 2024 (7.6% net margin).

Dividend & Returns

Yes, SiriusPoint Ltd. (SPNT) pays a dividend with a yield of 0.46%. This makes it attractive for income-focused investors.

SiriusPoint Ltd. (SPNT) has a return on equity (ROE) of 8.9%. This is below average, suggesting room for improvement.

Industry Metrics

SiriusPoint Ltd. (SPNT) has a combined ratio of 91.1%. A ratio below 100% indicates underwriting profitability.

US Stock Screener

...